Viscosity‐Responsive AIEgen TQ‐A1 for Real‐Time Imaging of Targeted Mitochondrial Fragmentation and Photodynamic Tumor Therapy
Open Access
- 14 February 2026
- journal article
- Published by Wiley in Small Structures
- Vol. 7 (2)
Abstract
Photosensitizers showing aggregation‐induced emission (AIE) that respond to local viscosity and target specific organelles are highly desirable for precise photodynamic therapy (PDT) and mechanistic imaging within biosystems. Here, we report a viscosity‐responsive AIEgen, called TQ‐A1, that selectively accumulates in mitochondria and enables real‐time visualization of mitochondrial fragmentation while delivering efficient PDT. TQ‐A1 has a donor– π –acceptor architecture with pronounced AIE characteristics, and its deep‐red emission is significantly enhanced in viscous or aggregated states. Single‐crystal analysis and quantum‐chemical calculations show that aggregation restricts intramolecular motion, lowers the reorganization energy, and suppresses nonradiative decay. Under light irradiation, TQ‐A1 generates both type I and type II reactive oxygen species, exhibits potent photocytotoxicity toward cancer cells, and displays excellent mitochondrial colocalization. Time‐lapse fluorescence imaging reveals a ROS‐driven morphological evolution of mitochondria from filamentous networks to granules, donuts, and compact clusters. In a HeLa xenograft model, the TQ‐A1‐mediated PDT markedly inhibits tumor growth without obvious systemic toxicity. These findings identify acetal‐tuned, viscosity‐responsive AIE photosensitizers as a useful platform for targeted mitochondrial imaging, real‐time tracking of organelle dynamics, and effective photodynamic tumor therapy.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFB3810001)
- National Natural Science Foundation of China (21788102)
- National Natural Science Foundation of China (52273197)
- National Natural Science Foundation of China (52333007)
This publication has 40 references indexed in Scilit:
- Mitochondria‐Targeted AIE Materials for Oxidative Stress‐Mediated Cancer Therapy and BeyondAggregate, 2025
- A “3+2” Cooperation Pattern of Amphipathic AIE Phototheranostic System for Multimodal Image‐Guided Synergistic Type I/II Photodynamic‐Photothermal TherapyAdvanced Science, 2025
- Tumor Site‐Specific In Vivo Theranostics Enabled by Microenvironment‐Dependent Chemical Transformation and Self‐Amplifying EffectAdvanced Science, 2024
- Optimizing Photosensitizers with Type I and Type II ROS Generation Through Modulating Triplet Lifetime and Intersystem Crossing EfficiencyAdvanced Functional Materials, 2024
- Exploring and leveraging aggregation effects on reactive oxygen species generation in photodynamic therapyAggregate, 2024
- Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular DegenerationAdvanced Science, 2023
- Self‐reporting fluorescence deciphers the antibacterial nature of cationic amphiphiles: Monomer or aggregate?Aggregate, 2023
- An AIE‐active probe for efficient detection and high‐throughput identification of outer membrane vesiclesAggregate, 2023
- Photosensitizers with Aggregation‐Induced Emission: Materials and Biomedical ApplicationsAdvanced Materials, 2018
- A Multifunctional Chemical Probe for the Measurement of Local Micropolarity and Microviscosity in MitochondriaAngewandte Chemie International Edition, 2018